Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05684796 · ClinicalTrials.gov registry record · NA
Comparison of Two Pulmonary Embolism Treatments
A NA study, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05684796 is a NA study that has completed, run by Penumbra. The registered enrollment target is 100 participants.
The verdict
NCT05684796, a NA study, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).
Interventions
- DRUG Anticoagulation
- DEVICE mechanical aspiration thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2025-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05684796
The ClinicalTrials.gov registry entry for NCT05684796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anticoagulation is the first listed.
NCT05684796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05684796 about?
NCT05684796 is a clinical study titled "Comparison of Two Pulmonary Embolism Treatments". The primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy with the Indigo Aspiration System for the treatment of intermediate-high risk acute pulmonary embolism (PE).
What is the current status of trial NCT05684796?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2023-11-27. Estimated completion is 2025-09-09.
What interventions are being tested in trial NCT05684796?
The interventions under investigation include: Anticoagulation (DRUG), mechanical aspiration thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT05684796?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.